What Has Been The Evolution of the Drug Infusion Systems Market in Recent Years?
The drug infusion systems market has seen considerable growth due to a variety of factors.
•The market size of drug infusion systems has experienced substantial growth in the recent past. It is projected to expand from $13.42 billion in 2024, reaching $14.34 billion in 2025, at a compound annual growth rate (CAGR) of 6.9%.
The considerable growth during the historical period can be ascribed to the transition towards electronic infusion devices, the rising occurrence of chronic health conditions, advancements in patient care, the introduction of home-based infusion therapy, and the broadening of ambulatory care settings.
What Is the Forecasted Market Size and Growth Rate for The Drug Infusion Systems Market?
The drug infusion systems market is expected to maintain its strong growth trajectory in upcoming years.
• The market for drug infusion systems is predicted to experience significant expansion in the coming years. It is projected to reach a size of "$20.46 billion by 2029, with a compound annual growth rate (CAGR) of 9.3%.
This anticipated growth over the forecast period can be credited to a move towards disposable systems, a rising incidence of chronic diseases, the development of ambulatory care centers, personalized medicine, and adaptive dosing, as well as a growing demand for home-based care. Notable trends during the forecast period are expected to include wireless connectivity and remote monitoring, integration with electronic health records (EHR), advanced pump technology, customised and adaptive dosing, and minimally invasive infusion methods.
What Factors Are Driving Growth In The Drug Infusion Systems Market?
The escalating occurrence of chronic illnesses is predicted to spur the expansion of the drug infusion system market. Chronic ailments like cancer, diabetes, cardiovascular disorders, and autoimmune diseases often necessitate extended or constant infusion treatment. Drug infusion systems provide a secure, efficient, and potent means of dispensing medication to patients suffering from these ailments. It's also seen that the prevalence of these diseases is growing more rapidly in low- and middle-income countries compared to high-income countries. Diabetes plays a crucial role in contributing to conditions like renal failure, heart attacks, strokes, blindness, and lower limb amputations. For illustration, the US-based Centers for Disease Control and Prevention (CDC) stated in its February 2024 reports that an increasing percentage of Americans are coping with multiple chronic conditions, with 42% having two or more and 12% suffering from five or more. Thus, the rising demand due to escalating prevalence of chronic illnesses is helping to boost the growth of the drug infusion system market.
What Are The Main Segments Of The Global Drug Infusion Systems Market?
The drug infusion systems market covered in this report is segmented –
1) By Product Type: Elastomeric Infusion System, Disposable Infusion System, Syringe Infusion System, Peristaltic Pump, Multi-Channel Pump, Patient-Controlled Analgesia (PCA) Pump, Insulin Pump, Implantable Infusion System
2) By Route Of Administration: Intravenous, Subcutaneous, Arterial, Epidural, Other Routes Of Administration
3) By Application: Oncology And Chemotherapy, Diabetes, Analgesia, Nutrition, Hematology, Pediatrics, Other Applications
4) By End User: Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Other End Users
Subsegments:
1) By Elastomeric Infusion System: Non-Vented Elastomeric Pumps, Vented Elastomeric Pumps
2) By Disposable Infusion System: Disposable Infusion Pumps, IV Sets With Disposable Components
3) By Syringe Infusion System: Manual Syringe Infusion Pumps, Electric Syringe Infusion Pumps
4) By Peristaltic Pump: Single-Channel Peristaltic Pumps, Multi-Channel Peristaltic Pumps
5) By Multi-Channel Pump: Multi-Channel Infusion Pumps For General Use, Multi-Channel Pumps For Specific Therapies
6) By Patient-Controlled Analgesia (PCA) Pump: Electronic PCA Pumps, Mechanical PCA Pumps
7) By Insulin Pump: Continuous Subcutaneous Insulin Infusion (CSII) Pumps, Patch Insulin Pumps
8) By Implantable Infusion System: Implantable Pumps For Chronic Pain, Implantable Pumps For Chemotherapy
Pre-Book The Drug Infusion Systems Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Emerging Trends Are Influencing The Growth Of The Drug Infusion Systems Market?
Significant players in the drug infusion systems market are innovating with cutting-edge technology such as cloud-based infusion management systems to boost patient care, enhance precision, and simplify the management of infusion therapies. These cloud-based systems are digital platforms that ease the supervision, execution, and tracking of medication infusions through the cloud. Eitan Medical, a leading global provider of advanced infusion therapy and drug delivery solutions based in the US, for instance, introduced Eitan Insights in June 2023. This novel cloud-based infusion management system caters to the specific requirements of home and specialty infusions. Eitan Insights offers healthcare professionals access to real-time data and statistics, allowing them to remotely monitor patients and modify treatment plans as required. This system boosts medication safety by lowering the chance of mistakes and enhancing the following of prescribed procedures.
Who Are the Key Players in the Drug Infusion Systems Market?
Major companies operating in the drug infusion systems market include:
• Medtronic plc
• Baxter International Inc.
• ICU Medical Inc.
• Becton Dickinson and Company
• Smiths Group plc
• Tandem Diabetes Care Inc.
• Terumo Corporation
• Halyard Health Inc.
• Insulet Corporation
• Zyno Medical Inc.
• Braun Melsungen AG
• Flowonix Medical Inc.
• IRadimed Corporation
• Moog Inc.
• Debiotech S.A.
• Fresenius SE & Co. KGaA
• Johnson & Johnson
• Hospira
• Alaris Health Systems Inc.
• B. Braun Melsungen AG
• Disetronic Medical Systems AG
• Accu-Chek
• Abbott Diabetes Care Inc.
• Novo Nordisk A/S
• Eli Lilly and Company
• Sanofi-Aventis
• Ypsomed Holding AG
• Valeritas Inc.
What Is The Most Dominant Region In The Drug Infusion Systems Market?
North America was the largest region in the drug infusion systems market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global drug infusion systems market report during the forecast period. The regions covered in the drug infusion systems market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
